Restrictive lung disease and serum TGF-beta1 in thalassemia major children

Suchada Sritippayawan1, Piyachat Lekhanont, Chanthana Harnruthakorn

  • 1Division of Pulmonology and Critical Care Medicine, King Chulalongkorn Memorial Hospital, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. suchadacu@hotmail.com

Insights

Restrictive lung disease in thalassemia major is linked to longer transfusion duration and higher ferritin. Serum TGF-beta1 levels did not show a significant association with restrictive lung disease in these children.

Area of Science:

  • Pediatric Hematology
  • Pulmonary Medicine
  • Biochemistry

Background:

  • Thalassemia major (TM) is a severe inherited blood disorder requiring lifelong transfusions.
  • Pulmonary complications, including restrictive lung disease (RLD), can affect TM patients.
  • The role of serum transforming growth factor-beta 1 (TGF-beta1) in RLD development in TM is not well understood.

Purpose of the Study:

  • To investigate the relationship between restrictive lung disease (RLD) and serum transforming growth factor-beta 1 (TGF-beta1) levels in children with thalassemia major.
  • To identify factors associated with RLD in this patient population.

Main Methods:

  • A cross-sectional study involving 21 children with thalassemia major.
  • Evaluation of pulmonary function, serum ferritin, and serum TGF-beta1 levels.
  • Comparison of RLD patients with non-RLD patients.

Main Results:

  • 24% of TM children exhibited restrictive lung disease (RLD).
  • RLD patients had significantly longer transfusion durations and higher serum ferritin levels compared to non-RLD patients.
  • Serum TGF-beta1 levels were significantly lower in TM children than in normal children, but not significantly different between RLD and non-RLD TM patients.

Conclusions:

  • Restrictive lung disease in thalassemia major is associated with prolonged transfusion history and elevated serum ferritin.
  • Serum TGF-beta1 levels do not appear to be a significant factor in the development of RLD in children with thalassemia major.